ABBV

AbbVie Inc. · Healthcare · Drug Manufacturers - General
$210.32
+3.85 (+1.86%)
Mkt Cap: 372.01B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield4.4%
Dividend YieldN/A
Market Cap372.01B
Volume4.69M
Recent News
2 dividend stocks to buy after Q1 earnings season
finbold.com · 2026-04-14
Erin Lichy Gets Real About Her Natrelle® Breast Augmentation
prnewswire.com · 2026-04-14
My Top 4 Pharma Picks Under Rising Geopolitical Risk
seekingalpha.com · 2026-04-13
Will AbbVie's Neuroscience Franchise Aid Top-line Growth in Q1?
zacks.com · 2026-04-13
S&P 500 Index Dividend Yields Are Teasing All-Time Lows. Here Are 3 Dividend Darlings That Crush This Trend.
fool.com · 2026-04-13
Haisco Enters into Exclusive License Agreement with AbbVie to Develop Novel Medicines for Pain
prnewswire.com · 2026-04-13

Unlock the Full Deep Scan

9 AI agents analyze ABBV across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →